We have several product candidates in development that we believe have been significantly de-risked.
We are committed to developing new drugs and commercializing them to the market, striving to improve human health, improve the quality of life, and reduce pain; and maximize patient savings throughout the process.
Click to know moreBalanced mix of new substance developments and life cycle management opportunities.
We focus on core competencies and its many years of experience. We thus hold a leading position in many therapeutic fields: for instance in the treatment of hemophilia and multiple sclerosis, in contrast media and oral contraception. We are also striving for such a leading position in oncology.
Dydrogesterone TrabectedinDirector ,
Click to see more
Project Leader with BD & Strategic Alliance ,
Click to see more
Director, USA ,
Click to see more
© Comhandhealth 2020 | Created with by J.Ryan